search

Fresenius Medical Care Corporation (FMS)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business
Sep 25, 2026

Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business

Fresenius Medical Care (FMS) announced a refined commercial strategy for China, which includes plans to exit its peritoneal dialysis business in the country. The article suggests that more details are available to premium subscribers, indicating a strategic shift for the company in the Chinese market.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Bearish
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to Brokerages
Sep 25, 2026

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to Brokerages

Eleven ratings firms have given Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) a "Reduce" recommendation, with an average 12-month price target of $23.57. Despite this cautious sentiment, the company reported stronger-than-expected quarterly results, with adjusted earnings of $0.66 per share and revenue of $5.55 billion. Institutional ownership of FMS stock has increased, although collective institutional holdings remain at 8.37%.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral